[vc_row][vc_column][vc_column_text]Dear Valued Stakeholders,
As we work to develop new cancer treatments for patients, I would first like to thank you for your ongoing support of OncoSec’s programs and business strategy. We are committed to providing timely corporate updates, including recent achievements and upcoming milestones. We are pleased to provide brief recaps of our conference calls to further expand our avenues of communication. We hope these continued activities further enhance shareholder engagement.
Continue reading “OncoSec Quarterly Update: July 2016”